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Background
Necrotizing Enterocolitis (NEC) is a disease that causes excessive inﬂammatory
necrosis within the intestines. It affects 10% of premature infants weighing under
1500 grams, and leads to increased morbidity and mortality, causing extensive
expenditure of healthcare dollars. This disease triggers devastatingly painful
symptoms within infants. Recent studies have shown that feeding infants breast milk
rather than formula milk can help alleviate the painful inﬂammation of this disease.
Moreover, supplementing a mother’s breast milk with probiotics has been shown to
enhance this anti-inﬂammatory effect. Currently, the focus towards ameliorating NEC
disease lies within determining the underlying mechanism of these ﬁndings.
Seeing that short chain fatty acids (SCFAs) are a metabolite of breast milk, and
have proven to help decrease inﬂammation within extant literature, this study focuses
on the anti-inﬂammatory effects of short chain fatty acid-butyrate within the intestines
of neonatal mice. Speciﬁcally, we used quantitative reverse transcription PCR
(RT-qPCR) to explore the relationship between short chain fatty acid butyrate and
intestinal barrier function genes. Intestinal genes were isolated and ampliﬁed from
neonatal mice in order to perform gene analysis through transcription proﬁling.
Preliminary results suggest potential relationships between anti-inﬂammatory effects
of short chain fatty acid butyrate and increased expression of Olcn, Cldn4, Muc1,
Muc2, Casp3, and Casp8 genes. If these ﬁndings can be replicated in human intestinal
cells, further understanding gene regulation can ultimately provide more effective and
efﬁcient treatment to neonatal infants.

Materials & Methods

Findings

Greater Implications

● Increasing short-chain fatty acids in infant diets can help
ameliorate & prevent NEC
○ (Ex: Carbohydrates in breast milk + Probiotics)
● Exploring the impact of short chain fatty acid butyrate as
it pertains to gene expression further elucidates the
underlying mechanisms of its anti-inﬂammatory effects
○ (Ex: Tight Junction genes, Ocln & Cldn4, in
Buty-IL1B mice shows expression higher than that of
control mice → Suggests that it has a role in Butyrate
reduced inﬂammation induced by IL1B)
● If these ﬁndings can be replicated in human intestinal
cells, further understanding gene regulation can provide
more speciﬁc treatment to neonatal infants
○ (Ex: Treating infants with speciﬁc short chain fatty
acids to regulate a speciﬁc gene)
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